Masimo Corp (MASI):企業の財務・戦略的SWOT分析

◆英語タイトル:Masimo Corp (MASI) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME1034FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Masimo Corp (MASI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Masimo Corp (Masimo) is a medical technology company that develops, manufactures and markets non-invasive patient monitoring technologies, medical devices and sensors to improve patient care. The company’s proprietary technologies include signal extraction technology (SET) that helps detect life threatening events; and rainbow SET platform. Its major products include patient monitors, pulse oximeters, central monitoring systems, specialty sensors, circuit boards, remote-alarms and monitoring solutions. Masimo markets products directly and also through a network of distributors and original equipment manufacturers to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long term care facilities and consumers. The company operates in North and South America, Europe, the Middle East, Africa, Asia, and Australia. Masimo is headquartered in Irvine, California, the US.

Masimo Corp Key Recent Developments

Feb 23,2021: Masimo reports fourth quarter and full-year 2020 financial results
Feb 16,2021: Masimo to Report Fourth Quarter and Full Year 2020 Financial Results after Market Close on Tuesday, February 23
Feb 10,2021: Masimo to Present in BTIG MedTech and Digital Health Conference
Jan 13,2021: Masimo announces select preliminary full-year 2020 financial results and 2021 guidance
Nov 03,2020: Masimo to acquire hemodynamic monitoring devices maker LiDCO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Masimo Corp – Key Facts
Masimo Corp – Key Employees
Masimo Corp – Key Employee Biographies
Masimo Corp – Major Products and Services
Masimo Corp – History
Masimo Corp – Company Statement
Masimo Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Masimo Corp – Business Description
Geographical Segment: Asia and Australia
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
Geographical Segment: North and South America (excluding United States)
Performance
Geographical Segment: United States
Performance
Masimo Corp – Corporate Strategy
Masimo Corp – SWOT Analysis
SWOT Analysis – Overview
Masimo Corp – Strengths
Masimo Corp – Weaknesses
Masimo Corp – Opportunities
Masimo Corp – Threats
Masimo Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Masimo Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Masimo Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Masimo Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 23, 2021: Masimo reports fourth quarter and full-year 2020 financial results
Feb 16, 2021: Masimo to Report Fourth Quarter and Full Year 2020 Financial Results after Market Close on Tuesday, February 23
Feb 10, 2021: Masimo to Present in BTIG MedTech and Digital Health Conference
Jan 13, 2021: Masimo announces select preliminary full-year 2020 financial results and 2021 guidance
Nov 03, 2020: Masimo to acquire hemodynamic monitoring devices maker LiDCO
Oct 27, 2020: Masimo reports third quarter 2020 financial results
Oct 06, 2020: Masimo announces select preliminary third quarter 2020 financial results and updated full-year 2020 guidance
Jul 28, 2020: Masimo reports second quarter 2020 financial results
Apr 28, 2020: Masimo reports first quarter 2020 financial results
Apr 01, 2020: Masimo announces preliminary, unaudited first quarter 2020 product revenue
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Masimo Corp, Key Facts
Masimo Corp, Key Employees
Masimo Corp, Key Employee Biographies
Masimo Corp, Major Products and Services
Masimo Corp, History
Masimo Corp, Subsidiaries
Masimo Corp, Key Competitors
Masimo Corp, Ratios based on current share price
Masimo Corp, Annual Ratios
Masimo Corp, Annual Ratios (Cont...1)
Masimo Corp, Annual Ratios (Cont...2)
Masimo Corp, Interim Ratios
Masimo Corp, Medical Equipment, Deals By Year, 2015 to YTD 2021
Masimo Corp, Medical Equipment, Deals By Type, 2015 to YTD 2021
Masimo Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Masimo Corp (MASI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Congenica Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers clinical decision support software and services. The company provides research and experimental development on biotechnology. Its technology SAPIENTIA is used to personalize patient care through accurate diagnoses, drug develop …
  • Petroleo Brasileiro SA (PETR4):企業の財務・戦略的SWOT分析
    Petroleo Brasileiro SA (PETR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sysmex Corp (6869):企業の製品パイプライン分析2018
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • Cardiatis SA:製品パイプライン分析
    Summary Cardiatis SA (Cardiatis) is a medical device company that develops a multilayer technology platform for endovascular aneurysm. The company offers a three dimensional multilayer braided stent system for endovascular aneurysm repair. Its multilayer flow modulator include aortic, peripheral, bi …
  • MicroPort Scientific Corp (853):企業の製品パイプライン分析2018
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, e …
  • Mochida Pharmaceutical Co Ltd (4534):企業の財務・戦略的SWOT分析
    Mochida Pharmaceutical Co Ltd (4534) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ophthotech Corp (OPHT):企業の財務・戦略的SWOT分析
    Summary Ophthotech Corp (Ophthotech) is a biopharmaceutical company that develops novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. The company’s products include Zimura, a complement inhibitor for stargardt disease. It also provides Fovista, a …
  • Electricity Supply Board
    Electricity Supply Board - Strategy, SWOT and Corporate Finance Report Summary Electricity Supply Board - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Clevexel Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Clevexel Pharma SAS (Clevexel) is a pharmaceutical company that develops drugs for the treatment of central nervous system diseases. The company’s pipeline product candidate includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease pat …
  • ITV plc:企業の戦略・SWOT・財務情報
    ITV plc - Strategy, SWOT and Corporate Finance Report Summary ITV plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Double Bond Pharmaceutical International AB (DBPB):製薬・医療:M&Aディール及び事業提携情報
    Summary Double Bond Pharmaceutical International AB (DBP) is a pharmaceutical company that design, develop and commercialize therapies for cancer and autoimmune diseases. The company’s product pipeline includes SI-053 (Temodex), a novel therapy to treat malignant brain tumors; SA-033, SA-042, and SA …
  • Baylor Scott & White Health-製薬・医療分野:企業M&A・提携分析
    Summary Baylor Scott & White Health (Baylor Scott & White) is a non-profit organization that provides medical care services. The organization provides medical education, medical services and conducts medical research. It offers medical services in the area of emergency care, cancer care, behavioral …
  • Herbalife Nutrition Ltd (HLF):企業の財務・戦略的SWOT分析
    Herbalife Nutrition Ltd (HLF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Puretech Health plc (PRTC):企業の財務・戦略的SWOT分析
    Summary Puretech Health plc (Puretech), formerly PureTech Ventures LLC, is a biopharmaceutical company that develops medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company develops a microbiome immune system drug-discovery platform and drug ca …
  • Nufarm Limited (NUF):企業の財務・戦略的SWOT分析
    Nufarm Limited (NUF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • T2 Biosystems Inc (TTOO):企業の財務・戦略的SWOT分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. T2 Biosystems offers T2HemoSta …
  • Iroko Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Iroko Pharmaceuticals LLC (Iroko) is a specialty pharmaceutical company that develops and commercializes pharmaceutical products. The company’s products comprise low dose Nonsteroidal anti-inflammatory drugs such as meloxicam, indomethacin, and diclofenac that are in various stages of noncli …
  • United Therapeutics Corp (UTHR):企業の財務・戦略的SWOT分析
    United Therapeutics Corp (UTHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Graftys SA-医療機器分野:企業M&A・提携分析
    Summary Graftys SA (Graftys) is a medical device company that focuses on the development, manufacture and commercialization of synthetic bioactive orthopedic biomaterials. It provides a wide range of synthetic and bioresorbable bone graft substitutes and other cement products. The company’s products …
  • AMETEK Inc (AME)-医療機器分野:企業M&A・提携分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆